Breakthrough Device Designation for Locate Bio’s LDGraft

Locate Bio LDGraft

Locate Bio was granted Breakthrough Device designation by FDA for LDGraft, currently in development for anterior lumbar interbody spinal fusion to treat degenerative disc disease.

LDGraft is designed to provide both an osteoconductive scaffold and a controlled and extended release of osteoinductive recombinant human bone morphogenetic protein...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us